or
forgot password

A Non-Interventional Retrospective Correlation Of Tumor Mutation Status To Clinical Benefit From The SU011248, A6181036 Treatment Protocol Titled: A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate


N/A
18 Years
N/A
Not Enrolling
Both
GIST

Thank you

Trial Information

A Non-Interventional Retrospective Correlation Of Tumor Mutation Status To Clinical Benefit From The SU011248, A6181036 Treatment Protocol Titled: A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate


This is a non-interventional trial. No active patients will participate in this study.
Only data generated from the A6181036 study will be utilized for correlational purposes. The
A6181036 study data in addition to mutational status data previously analyzed but not
collected as part of the A6181036 study in the same patient population


Inclusion Criteria:



- GIST subjects that participated in the A6181036 study that had mutational status data
analyzed.

Exclusion Criteria:

- Subjects not participating in the A6181036 study

Type of Study:

Observational

Study Design:

Time Perspective: Retrospective

Outcome Measure:

Mutational status data retrospectively accessed correlated with A6181036 clinical outcomes data in GIST subjects treated with sunitinib

Outcome Time Frame:

9 months

Safety Issue:

No

Principal Investigator

Pfizer CT.gov Call Center

Investigator Role:

Study Director

Investigator Affiliation:

Pfizer

Authority:

United States: Food and Drug Administration

Study ID:

A6181199

NCT ID:

NCT01459757

Start Date:

October 2011

Completion Date:

April 2013

Related Keywords:

  • GIST
  • Retrospective
  • GIST
  • sunitinib
  • mutational
  • Gastrointestinal Stromal Tumors

Name

Location
Dana-Farber Cancer Institute Boston, Massachusetts  02115
Brigham and Women's Hospital Boston, Massachusetts  02115
Seattle Cancer Care Alliance Seattle, Washington  98109
Washington Hospital Center Washington, District of Columbia  20010
University of Washington Seattle, Washington  98195
City of Hope Duarte, California  91010
Moffitt Cancer Center Tampa, Florida  33612
Oregon Health and Science University Portland, Oregon  97201
Shands Hospital at the University of Florida Gainesville, Florida  32610
Shands Cancer Hospital at the University of Florida Gainesville, Florida  32608
Davis Cancer Pavilion and Shands Medical Plaza Gainesville, Florida  32608
Masonic Cancer Center - Clinical Trials Office Minneapolis, Minnesota  55455